Healthcare provider profile · identity verified

Nilo Santos, MD

Internal Medicine · AUBURN, WA · NPI 1952345084

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	475	134
Amlodipine Besylate	Amlodipine Besylate	304	88
Lisinopril	Lisinopril	248	65
Metoprolol Succinate	Metoprolol Succinate	161	41
Losartan Potassium	Losartan Potassium	140	39
Omeprazole	Omeprazole	138	34
Tamsulosin Hcl	Tamsulosin Hcl	135	38
Gabapentin	Gabapentin	111	30
Hydrochlorothiazide	Hydrochlorothiazide	111	30
Allopurinol	Allopurinol	108	29
Rosuvastatin Calcium	Rosuvastatin Calcium	108	35
Fluoxetine Hcl	Fluoxetine Hcl	94	27
Simvastatin	Simvastatin	92	24
Metformin Hcl	Metformin Hcl	88	28
Levothyroxine Sodium	Levothyroxine Sodium	86	22
Metformin Hcl Er	Metformin Hcl	79	20
Albuterol Sulfate Hfa	Albuterol Sulfate	78	27
Furosemide	Furosemide	76	15
Trazodone Hcl	Trazodone Hcl	70	22
Potassium Chloride	Potassium Chloride	68	15
Ezetimibe	Ezetimibe	58	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	17
Zolpidem Tartrate	Zolpidem Tartrate	57	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	50	12
Fluticasone Propionate	Fluticasone Propionate	49	17
Metoprolol Tartrate	Metoprolol Tartrate	48	11
Alendronate Sodium	Alendronate Sodium	46	15
Glipizide Er	Glipizide	45	15
Meloxicam	Meloxicam	41	suppressed
Lovastatin	Lovastatin	39	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	11
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	37	suppressed
Citalopram Hbr	Citalopram Hydrobromide	31	suppressed
Donepezil Hcl	Donepezil Hcl	28	suppressed
Glipizide	Glipizide	28	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Buspirone Hcl	Buspirone Hcl	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Pravastatin Sodium	Pravastatin Sodium	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Finasteride	Finasteride	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Gemfibrozil	Gemfibrozil	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Benazepril Hcl	Benazepril Hcl	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Atenolol	Atenolol	18	suppressed
Baclofen	Baclofen	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Famotidine	Famotidine	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	14
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Prednisone	Prednisone	14	14
Sertraline Hcl	Sertraline Hcl	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	suppressed
Eliquis	Apixaban	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Donepezil Hcl Odt	Donepezil Hcl	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ozempic	Semaglutide	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error